Abstract
Familial heterozygous hypercholesterolaemia is the most relevant lipid disorder, which diminishes the life expectancy of affected patients by 15–30 years. Diagnosis in childhood can be easily established by LDL-cholesterol screening – and in case of elevated levels – genetic testing. Early therapy improves prognosis significantly. The Vroni study analyses the feasibility and efficiency of a population-wide screening for FH in order to improve the treatment of affected families.
| Translated title of the contribution | Familial hypercholesterolaemia - Target of the Vroni study |
|---|---|
| Original language | German |
| Pages (from-to) | 414-421 |
| Number of pages | 8 |
| Journal | Tagliche Praxis |
| Volume | 65 |
| Issue number | 3 |
| State | Published - 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Familial hypercholesterolaemia - Target of the Vroni study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver